Does UPADACITINIB Cause Off label use? 1,164 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,164 reports of Off label use have been filed in association with UPADACITINIB (Rinvoq). This represents 1.8% of all adverse event reports for UPADACITINIB.
1,164
Reports of Off label use with UPADACITINIB
1.8%
of all UPADACITINIB reports
39
Deaths
196
Hospitalizations
How Dangerous Is Off label use From UPADACITINIB?
Of the 1,164 reports, 39 (3.4%) resulted in death, 196 (16.8%) required hospitalization, and 45 (3.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 1,164 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which UPADACITINIB Alternatives Have Lower Off label use Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL